Companies: 10,795·Total market cap: $144.5T
CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation

CAMPNASDAQHealthcare● Active
$4.23
+$0.14(+3.30%)
Market Cap$89739942
P/E Ratio
52W High$7.75
52W Low$1.305

CAMP4 Therapeutics Corporation(CAMP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CAMP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-112023-022022-02
Revenue
Revenue$3.50M$0.65M$0.35M$0.00M$295.84M
Cost of Revenue$1.64M$0.00M$0.00M$0.00M$173.95M
Gross Profit$1.86M$0.65M$0.35M$0.00M$121.89M
Gross Margin %(computed)53.14%100.00%100.00%41.20%
Operating Expenses
R&D Expenses$38.20M$38.82M$40.62M$34.77M$28.44M
G&A Expenses$17.36M$14.92M$11.61M$10.23M$52.33M
Total Operating Expenses$53.92M$53.74M$52.23M$45.00M$134.76M
Operating Income($52.06M)($53.09M)($51.88M)($45.00M)($15.31M)
Operating Margin %(computed)-5.18%
Interest Income$2.17M$1.33M$2.81M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$6.26M$15.32M
Income Before Tax($80.40M)($51.79M)($49.29M)($44.19M)($30.06M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$1.09M
Net Income($80.40M)($51.79M)($49.29M)($44.19M)($31.15M)
Net Margin %(computed)-10.53%
Per Share & EBITDA
EPS (Basic)$-2.65$-2.66$-4.07$-0.90$-0.88
Wtd Avg Shares30.38M19.51M12.12M36.10M35.25M
EBITDA($50.42M)($51.39M)($50.20M)($44.12M)$7.49M
EBITDA Margin %(computed)2.53%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解CAMP4 Therapeutics Corporation

关于CAMP4 Therapeutics Corporation(CAMP)损益表

CAMP4 Therapeutics Corporation(CAMP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CAMP实现营收$0.00B,毛利润$0.00B(毛利率53.14%),净利润($0.08B)(净利率-2298.54%)。

常见问题

CAMP · 4 问

CAMP4 Therapeutics Corporation(CAMP)2025财年营收为$0.00B,同比up436.5%。

CAMP revenueCAMP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09